Want to create an interactive transcript for this episode?
Podcast: Clinician's Roundtable
Episode: Expert Debate: The Ethics of Consumer Genetic Testing
Description:
Host: David Weisman, MD
Guest: John Khoury, MD
For the first time, the FDA has approved a direct-to-consumer genetic test from 23andme that will inform patients if they are predisposed to diseases such as Parkinson’s, Alzheimer's, and Celiac Disease among others. Proponents applaud this decision, saying this will allow for people to know their genetic health risks and be more proactive about their health. Others argue that this information doesn’t tell the whole story since predisposition doesn't reflect someone's ultimate risk or likelihood of developing a disease. What are the benefits and liabilities of c...